Linezolid is an oxazolidinone antibiotic with activity against gram-positive organisms, particularly methicillin-resistant Staphylococcus aureus (MRSA). To the best of our knowledge, there are only two case reports on rhabdomyolysis in patients treated with linezolid. Here, we describe two cases of serious rhabdomyolysis: one in a patient with septic community-acquired (CA)-MRSA pneumonia and a second case in a patient with suspected catheter-related blood stream infection.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5529475 | PMC |
| http://dx.doi.org/10.1007/s15010-016-0978-8 | DOI Listing |
Publication Analysis
Top Keywords
cases serious
8
serious rhabdomyolysis
8
rhabdomyolysis linezolid
4
linezolid treatment
4
treatment linezolid
4
linezolid oxazolidinone
4
oxazolidinone antibiotic
4
antibiotic activity
4
activity gram-positive
4
gram-positive organisms
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!